Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- SECSEC Form 25-NSE filed by Financial Strategies Acquisition Corp.25-NSE - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECSEC Form NT 10-Q filed by Financial Strategies Acquisition Corp.NT 10-Q - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECSEC Form NT 10-K filed by Financial Strategies Acquisition Corp.NT 10-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- 13D/GSEC Form SC 13G filed by Financial Strategies Acquisition Corp.SC 13G - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- SECSEC Form 425 filed by Financial Strategies Acquisition Corp.425 - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- 13D/GSEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- 13D/GSEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- NEWSFinancial Strategies Acquisition Corp. Announces Merger With Austin Biosciences Corp, A Texas Biotechnology Platform Company; Austin Biosciences's Shareholders Will Receive An Aggregate Of 12.5M Shares Of FXCO's Class A Common StockFinancial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ASTN." Austin Biosciences Corporation Highlights Austin Biosciences is a p
- PRFinancial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, A Texas Biotechnology Platform CompanyDALLAS and AUSTIN, Texas, Feb. 13, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company'
- PRFinancial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination DateDALLAS, Feb. 9, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination.
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- 13D/GSEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- INSIDERSEC Form 4: Schinzing Alexander V converted options into 1,851,250 shares4 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Financial Strategies Acquisition Corp. (Amendment)SC 13D/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Leadership Update8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- SECFinancial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
- NEWSFinancial Strategies Acquisition Announces Extension Of Termination Date, Additional Contribution To Trust Account To Extend Termination Date
FXCO FAQ
6 questionsWhat does Financial Strategies Acquisition Corp. do?
Financial Strategies Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company focuses on identifying businesses in the financial technology and financial services sector. Financial Strategies Acquisition Corp. was incorporated in 2020 and is based in Dallas, Texas.Where does FXCO stock trade?
Financial Strategies Acquisition Corp. (FXCO) is listed on NASDAQ.What sector and industry is FXCO in?
Financial Strategies Acquisition Corp. operates in the Finance sector, Blank Checks industry.When did Financial Strategies Acquisition Corp. go public?
Financial Strategies Acquisition Corp. (FXCO) completed its IPO in 2023.What companies are similar to FXCO?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare FXCO side-by-side with any of them on Quantisnow.How can I track FXCO on Quantisnow?
Quantisnow aggregates Financial Strategies Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FXCO to receive live email and push alerts on every new disclosure.